Herbal Wisdom for Alzheimer's Disease: A Comprehensive Review
Authors
-
Department of Pharmacy, Sumandeep Vidyapeeth Deemed to be University, Vadodara – 31760, Gujarat ,IN
Cyril Sajan -
Department of Pharmacy, Sumandeep Vidyapeeth Deemed to be University, Vadodara – 31760, Gujarat ,INKrima Doshi
-
Department of Pharmacy, Sumandeep Vidyapeeth Deemed to be University, Vadodara – 31760, Gujarat ,INVarunsingh Saggu
-
Department of Pharmacy, Sumandeep Vidyapeeth Deemed to be University, Vadodara – 31760, Gujarat ,INDilsar Gohil
-
Department of Pharmacy, Sumandeep Vidyapeeth Deemed to be University, Vadodara – 31760, Gujarat ,INRajesh Hadia
-
Department of Pharmacy, Sumandeep Vidyapeeth Deemed to be University, Vadodara – 31760, Gujarat ,INHemraj Singh Rajput
DOI:
https://doi.org/10.18311/jnr/2024/43485Keywords:
Alzheimer's, Nutraceuticals, Remedies, DiseaseAbstract
Alzheimer's Disease (AD) is a progressive disorder that leads to the degeneration of nerve cells, marked by a decline in cognitive abilities, including memory, reasoning, and behaviour. It stands as the primary cause of dementia in the elderly, leading to a gradual erosion of autonomy. Despite considerable research efforts, a definitive cure for AD remains out of reach, with existing treatments mainly focused on alleviating symptoms. The intricate nature of AD, which involves multiple pathological mechanisms, indicates that drugs targeting a single pathway might be inadequate. Herbal remedies, renowned for their diverse and multifunctional properties, present a promising alternative. This review examines the potential of herbal remedies to act as effective pharmaceuticals and nutraceuticals in treating and preventing AD. By addressing various aspects of AD concurrently, these natural therapies offer a new and hopeful strategy for managing this debilitating condition.
Downloads
Metrics
Published
How to Cite
License
Copyright (c) 2024 Cyril Sajan, Krima Doshi, Varunsingh Saggu, Dilsar Gohil, Rajesh Hadia, Hemraj Singh Rajput (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Accepted 2024-06-26
Published 2024-08-31
References
Finder VH. Alzheimer's disease: A general introduction and pathomechanism. J Alzheimer's Dis. 2010; 22(s3):S5–19. https://doi.org/10.3233/JAD-2010-100975 PMid:20858960
Daffner KR, Scinto LF. Early diagnosis of Alzheimer's disease: An introduction. Early diagnosis of Alzheimer's disease. Totowa, NJ: Humana Press; 2000. p. 1-27. https:// doi.org/10.1007/978-1-59259-005-6_1
Kumar A, Singh A. A review on Alzheimer's disease pathophysiology and its management: An update. Pharm Rep. 2015; 67(2):195-203. https://doi.org/10.1016/j.pharep.2014.09.004 PMid:25712639
Soheili M, Karimian M, Hamidi G, Salami M. Alzheimer's disease treatment: The share of herbal medicines. Iran J Basic Med Sci. 2021; 24(2):123.
Joe E, Ringman JM. Cognitive symptoms of Alzheimer's disease: Clinical management and prevention. BMJ. 2019; 367. https://doi.org/10.1136/bmj.l6217 PMid:31810978
Masters MC, Morris JC, Roe CM. Noncognitive symptoms of early Alzheimer disease: A longitudinal analysis. Neurol. 2015; 84(6):617-22. https://doi.org/10.1212/WNL.0000000000001238 PMid:25589671 PMCid:PMC4335988
Singhal AK, Naithani V, Bangar OP. Medicinal plants with a potential to treat Alzheimer and associated symptoms. Int J Nutr Pharmacol Neurol Dis. 2012; 2(2):84-91. https://doi.org/10.4103/2231-0738.95927
Gauthier S. Cholinergic adverse effects of cholinesterase inhibitors in Alzheimer's disease: Epidemiology and management. Drugs Aging. 2001; 18:853-62. https://doi.org/10.2165/00002512-200118110-00006 PMid:11772125
Brady R, Weinman J. Adherence to cholinesterase inhibitors in Alzheimer's disease: A review. Dement Geriatr Cogn Disord. 2013; 35(5-6):351-63. https://doi.org/10.1159/000347140 PMid:23635412
Ruangritchankul S, Chantharit P, Srisuma S, Gray LC. Adverse drug reactions of acetylcholinesterase inhibitors in older people living with dementia: A comprehensive literature review. Ther Clin Risk Manag. 2021:927-49. https://doi.org/10.2147/TCRM.S323387 PMid:34511919 PMCid:PMC8427072
Tanaka A, Koga S, Hiramatsu Y. Donepezil-induced adverse side effects of cardiac rhythm: 2 cases report of atrioventricular block and Torsade de Pointes. Intern Med. 2009; 48(14):1219-23 https://doi.org/10.2169/ internalmedicine.48.2181 PMid:19602789
Alaghband-Rad J, Nikvarz N, Tehrani-Doost M, Ghaeli P. Memantine-induced speech problems in two patients with autistic disorder. DARU J Pharm Sci. 2013; 21:1-3. https://doi.org/10.1186/2008-2231-21-54 PMid:23819879 PMCid:PMC3711986
Van Marum RJ. Update on the use of memantine in Alzheimer's disease. Neuropsychiatr Dis Treat. 2009:23747. https://doi.org/10.2147/NDT.S4048 PMid:19557118 PMCid:PMC2695219
Russo A, Izzo AA, Cardile V, Borrelli F, Vanella A. Indian medicinal plants as antiradicals and DNA cleavage protectors. Phytomed. 2001; 8(2):125-32. https://doi.org/10.1078/0944-7113-00021 PMid:11315755
Xu Q, Zhang L, Yu J, Wageh S, Al-Ghamdi AA, Jaroniec M. Direct Z-scheme photocatalysts: Principles, synthesis, and applications. Mat Today. 2018; 21(10):1042-63. https://doi.org/10.1016/j.mattod.2018.04.008
Singh AK, Rai SN, Maurya A, Mishra G, Awasthi R, Shakya A, et al. Therapeutic potential of phytoconstituents in management of Alzheimer's disease. Evid Based Complement Alternat Med. 2021; 2021:1-9. https://doi.org/10.1155/2021/5578574 PMid:34211570 PMCid: PMC8208882
Baum L, Lam CW, Cheung SK, Kwok T, Lui V, Tsoh J, et al. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol. 2008; 28(1):110-3. https:// doi.org/10.1097/jcp.0b013e318160862c PMid:18204357
Hamaguchi T, Ono K, Yamada M. Curcumin and Alzheimer's disease. CNS Neurosci Ther. 2010; 16(5): 285-97. https://doi.org/10.1111/j.1755-5949.2010.00147.x PMid:20406252 PMCid:PMC6493893
Park SY, Kim DS. Discovery of natural products from Curcuma longa that protect cells from beta-amyloid insult: A drug discovery effort against Alzheimer's disease. J Nat Prod. 2002; 65(9):1227-31. https://doi.org/10.1021/ np010039x PMid:12350137
Mehla J, Gupta P, Pahuja M, Diwan D, Diksha D. Indian medicinal herbs and formulations for Alzheimer's disease, from traditional knowledge to scientific assessment. Brain Sci. 2020; 10(12):964. https://doi.org/10.3390/ brainsci10120964 PMid:33321899 PMCid:PMC7764187
Bihaqi SW, Sharma M, Singh AP, Tiwari M. Neuroprotective role of Convolvulus pluricaulis on aluminium induced neurotoxicity in rat brain. J Ethnopharmacol. 2009; 124(3):409-15. https://doi.org/10.1016/j.jep.2009.05.038 PMid:19505562
Shi C, Liu J, Wu F, Yew DT. Ginkgo biloba extract in Alzheimer's disease: from action mechanisms to medical practice. Int J Mol Sci. 2010; 11(1):107-23. https://doi.org/10.3390/ijms11010107 PMid:20162004 PMCid:PMC2820992
Dabhekar SV, Chandurkar PA, Kale MB, Wankhede NL, Taksande BG, Umekar MJ, et al. Herbal medicine in the treatment of Alzheimer's Disease and Dementia: Phytoconstituent and their possible pharmacological activities. Depr Anxiet. 2022; 5:1002.
Pai V, Shreedhara CS, Chandrashekar KS, Pai A, Kamath V. Cognitive enhancement and neuroprotective effects of ancient ayurvedic medicinal plant Celastrus paniculatus: An overview. Res J Pharm Technol. 2016; 9(8):1295-8. https:// doi.org/10.5958/0974-360X.2016.00246.8
Essa MM, Vijayan RK, Gonzalez GC, Memon MA, Braidy N, et al. Neuroprotective effect of natural products against Alzheimer's disease. Neurochem Res. 2012; 37:1829-42. https://doi.org/10.1007/s11064-012-0799-9 PMid:22614926
Rojas CT, Opazo FC, Deaton CA, Vergara EH, Johnson GV, et al. It's all about tau. Prog Neurobiol. 2019; 175: 54-76. https://doi.org/10.1016/j.pneurobio.2018.12.005 PMid:30605723 PMCid:PMC6397676
Asgarpanah J, Kazemivash N. Phytochemistry and pharmacologic properties of Myristica fragrans Hoyutt.: A review. Afr J Biotechnol. 2012; 11(65):12787-93. https://doi.org/10.5897/AJB12.1043
Mutalik M, Mutalik M. Tinospora cordifolia: Role in depression, cognition and memory. Aust J Herb Med. 2011; 23(4):168-73.
Dubey T, Chinnathambi S. Brahmi (Bacopa monnieri): An ayurvedic herb against the Alzheimer's disease. Arch Biochem Biophy. 2019; 676:108153. https://doi.org/10.1016/j.abb.2019.108153 PMid:31622587
Chakraborty B, Mukerjee N, Maitra S, Zehravi M, Mukherjee D, Ghosh A, et al. Therapeutic potential of different natural products for the treatment of Alzheimer's Disease. Oxid Med Cell Longev. 2022; 2022. https://doi.org/10.1155/2022/6873874 PMid:35910833 PMCid:PMC9337964
Gangul R, Guha D. Alteration of brain monoamines and EEG wave pattern in rat model of Alzheimer's disease and protection by Moringa oleifera. Indian J Med Res. 2008; 128.
Vasudevan M, Parle M. Memory enhancing activity of Anwalachurna (Emblica officinalis Gaertn.): An Ayurvedic preparation. Physiol Behav. 2007; 91:46-54. https://doi.org/10.1016/j.physbeh.2007.01.016 PMid:17343883
Ramachandran S, Sanjay AS, Dhanaraju MD. Antiamnesic effect of Piracetam potentiated with Emblica officinalis and Curcuma longa in aluminium induced neurotoxicity of Alzheimer's disease. Int J Adv Res. 2013; 1:85-196.
Siddiqui A, Shah Z, Jahan RN, Othman I, Kumari Y. Mechanistic role of boswellic acids in Alzheimer's disease: Emphasis on anti-inflammatory properties. Biomed Pharmacother. 2021; 144:112250. https://doi.org/10.1016/j.biopha.2021.112250 PMid:34607104
Singhal AK, Naithani V, Bangar OP. Medicinal plants with a potential to treat Alzheimer and associated symptoms. Int J Nutr Pharmacol Neurol Dis. 2012; 2(2):84-91. https://doi.org/10.4103/2231-0738.95927
Perluigi M, Joshi G, Sultana R, Calabrese V, De Marco C, Coccia R, et al. In vivo protective effects of ferulic acid ethyl ester against amyloid‐beta peptide 1-42‐induced oxidative stress. J Neurosci Res. 2006; 84(2):418-26. https://doi.org/10.1002/jnr.20879 PMid:16634068
Kim HG, Oh MS. Herbal medicines for the prevention and treatment of Alzheimer's disease. Curr Pharm Des. 2012; 18(1):57-75. https://doi.org/10.2174/138161212798919002
Little JT, Walsh S, Aisen PS. An update on huperzine A as a treatment for Alzheimer's disease. Curr Pharm Des. 2008; 17(2):209-15. https://doi.org/10.1517/13543784.17.2.209 PMid:18230054
Xing SH, Zhu CX, Zhang R, An L. Huperzine a in the treatment of Alzheimer's disease and vascular dementia: a meta-analysis. J Evid Based Complementary Altern Med. 2014; 2014. https://doi.org/10.1155/2014/363985 PMid:24639880 PMCid:PMC3930088
Daf MA, Kapse MA, Pise MS, Makade MK, Sawarkar MD, Mundhada DR. A review on: Synthetic and herbal approaches for the treatment of Alzheimer's disease. Int J Pharm Sci Res. 2023; 8(3):1381-414.
Erdö SL, Ning-sheng C, Wolff JR, Kiss B. Vinpocetin protects against excitotoxic cell death in primary cultures of rat cerebral cortex. Eur J Pharmacol. 1990; 187(3):551-3. https://doi.org/10.1016/0014-2999(90)90386-K PMid:1981558
Bönöczk P, Gulyás B, Adam-Vizi V, Nemes A, Kárpáti E, Kiss B, et al. Role of sodium channel inhibition in neuroprotection: Effect of vinpocetine. Brain Res Bull. 2000; 53(3):245-54. https://doi.org/10.1016/S03619230(00)00354-3 PMid:11113577
Deshmukh R, Sharma V, Mehan S, Sharma N, Bedi KL. Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine-a PDE1 inhibitor. Eur J Pharmacol. 2009; 620(1-3):49-56. https://doi.org/10.1016/j.ejphar.2009.08.027 PMid:19699735
Singh A, Duggal S, Singh H, Singh J, Katekhaye S. Withanolides: Phytoconstituents with significant pharmacological activities. Int J Green Pharm. 2010; 4(4):74130. https://doi.org/10.4103/0973-8258.74130
Soleimani V, Sahebkar A, Hosseinzadeh H. Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances. Phytother Res. 2018; 32(6):98595. https://doi.org/10.1002/ptr.6054 PMid:29480523
Zhang S, Huang Y, Li Y, Wang Y, He X. Antineuroinflammatory and antioxidant phenylpropanoids from Chinese olive. Food Chem. 2019; 286:421-7. https:// doi.org/10.1016/j.foodchem.2019.02.031 PMid:30827627
Zeppilli D, Ribaudo G, Pompermaier N, Madabeni A, Bortoli M, Orian L. Radical scavenging potential of ginkgolides and bilobalide: Insight from molecular modeling. Antioxid. 2023; 12(2):525. https://doi.org/10.3390/antiox12020525 PMid:36830083 PMCid:PMC9952587
Katekhaye S, Duggal S, Singh AP. An inside preview of nutritional and pharmacological profile of Celastrus paniculatus. Int J Recent Adv Pharm Res. 2011; 1:19-24.
Song JH, Lee JW, Shim B, Lee CY, Choi S, Kang C, et al. Glycyrrhizin alleviates neuroinflammation and memory deficit induced by systemic lipopolysaccharide treatment in mice. Molecules. 2013; 18(12):15788-803. https://doi.org/10.3390/ molecules181215788 PMid:24352029 PMCid: PMC6269849
Seneme EF, Dos Santos DC, Silva EM, Franco YE, Longato GB. Pharmacological and therapeutic potential of myristicin: A literature review. Molecules. 2021; 26(19):5914. https://doi.org/10.3390/molecules26195914 PMid:34641457 PMCid:PMC8512857
Onoja OJ, Elufioye TO, Sherwani ZA, Ul-Haq Z. Molecular docking studies and anti-Alzheimer's potential of isolated compounds from Tinospora cordifolia. J Biol Act Prod Nat. 2020; 10(2):100-21. https://doi.org/10.1080/22311866.20201726813
Fatima U, Roy S, Ahmad S, Ali S, Elkady WM, Khan I, et al. Pharmacological attributes of Bacopa monnieri extract: Current updates and clinical manifestation. Front Nutr. 2022; 9:972379. https://doi.org/10.3389/fnut.2022.972379 PMid:36061899 PMCid:PMC9436272
Niki E, Abe K. Vitamin E: Structure, properties and functions: Chemistry and nutritional benefits. Vitamin E; 2019. p. 1-11.
Türkan F, Taslimi P, Saltan FZ. Tannic acid as a natural antioxidant compound: Discovery of a potent metabolic enzyme inhibitor for a new therapeutic approach in diabetes and Alzheimer's disease. J Biochem Mol Toxicol. 2019; 33(8):e22340. https://doi.org/10.1002/jbt.22340 PMid: 30974029
Haghaei H, Soltani S, Hosseini SA, Rashidi MR, Karima S. Boswellic acids as promising leads in drug development against Alzheimer's disease. Pharm Sci. 2020; 27(1):14-31. https://doi.org/10.34172/PS.2020.25
Zhang Z, Liu J, Guo M, Li H. Panax ginseng in the treatment of Alzheimer's disease and vascular dementia. J Ginseng Res. 2023. https://doi.org/10.1016/j.jgr.2023.03.001 PMid: 37397417 PMCid:PMC10310864
Bai DL, Tang XC, He XC. Huperzine A, a potential therapeutic agent for treatment of Alzheimer's disease. Curr Med Chem. 2000; 7(3):355-74. https://doi.org/10.2174/0929867003375281 PMid:10637369
Marco-Contelles J, Rodríguez C, García AG. Chemical synthesis of galantamine, an acetylcholinesterase inhibitor for treatment of Alzheimer's disease. Expert Opin Ther Pat. 2005; 15(5):575-87. https://doi.org/10.1517/13543776.15.5.575
Patyar S, Prakash A, Modi M, Medhi B. Role of vinpocetine in cerebrovascular diseases. Pharmacol. Rep. 2011; 63(3):618-28. https://doi.org/10.1016/S1734-1140(11)70574-6 PMid:21857073
Debas HT, Laxminarayan R, Straus SE. Complementary and alternative medicine. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, et al. editors. Disease control priorities in developing countries. 2nd edition. Washington (DC): The International Bank for Reconstruction and Development/The World Bank; 2006. Chapter 69.
0.35
24
0.161